ChampionX [CHX] vs Nov [NOV] Detailed Stock Comparison

ChampionX
NASDAQ
Loading...

Nov
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: ChampionX wins in 9 metrics, Nov wins in 11 metrics, with 0 ties. Nov appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | ChampionX | Nov | Better |
---|---|---|---|
P/E Ratio (TTM) | 17.09 | 11.32 | Nov |
Price-to-Book Ratio | 2.58 | 0.79 | Nov |
Debt-to-Equity Ratio | 34.38 | 36.15 | ChampionX |
PEG Ratio | 13.04 | -0.23 | Nov |
EV/EBITDA | 6.40 | 5.43 | Nov |
Profit Margin (TTM) | 8.20% | 5.36% | ChampionX |
Operating Margin (TTM) | 14.42% | 6.54% | ChampionX |
EBITDA Margin (TTM) | 14.42% | 6.54% | ChampionX |
Return on Equity | 16.83% | 7.38% | ChampionX |
Return on Assets (TTM) | 9.44% | 4.45% | ChampionX |
Free Cash Flow (TTM) | $448.37M | $953.00M | Nov |
Dividend Yield | 1.90% | 1.52% | ChampionX |
1-Year Return | -26.45% | -17.08% | Nov |
Price-to-Sales Ratio (TTM) | 1.38 | 0.58 | Nov |
Enterprise Value | $4.87B | $6.43B | Nov |
EV/Revenue Ratio | 1.36 | 0.73 | Nov |
Gross Profit Margin (TTM) | 33.72% | 20.38% | ChampionX |
Revenue per Share (TTM) | $19 | $23 | Nov |
Earnings per Share (Diluted) | $1.51 | $1.21 | ChampionX |
Beta (Stock Volatility) | 1.51 | 1.26 | Nov |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
ChampionX vs Nov Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
ChampionX | 0.00% | -3.04% | -2.23% | 4.54% | -11.46% | -5.46% |
Nov | -0.80% | 2.57% | 2.64% | 6.76% | 13.82% | -7.55% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
ChampionX | -26.45% | 32.97% | 166.63% | -32.08% | -32.08% | -32.08% |
Nov | -17.08% | -23.99% | 58.02% | -65.51% | -68.99% | -46.52% |
News Based Sentiment: ChampionX vs Nov
ChampionX
News sentiment data is not available for ChampionX at this time.
Nov
News based Sentiment: MIXED
The month presented a mixed bag of news for NOV Inc., with a slight earnings miss, a revenue beat, conflicting analyst ratings, and unusual options activity. While there are some positive signals, the overall picture is one of caution and uncertainty, making it a moderately important month for investors.
Performance & Financial Health Analysis: ChampionX vs Nov
Metric | CHX | NOV |
---|---|---|
Market Information | ||
Market Cap | $4.94B | $5.18B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 2,539,777 | 3,723,450 |
90 Day Avg. Volume | 2,969,606 | 3,578,040 |
Last Close | $25.81 | $13.59 |
52 Week Range | $21.92 - $35.94 | $10.84 - $16.86 |
% from 52W High | -28.19% | -19.40% |
All-Time High | $46.11 (May 21, 2018) | $86.55 (Sep 01, 2014) |
% from All-Time High | -44.03% | -84.30% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.06% | -0.01% |
Quarterly Earnings Growth | -0.24% | -0.52% |
Financial Health | ||
Profit Margin (TTM) | 0.08% | 0.05% |
Operating Margin (TTM) | 0.14% | 0.07% |
Return on Equity (TTM) | 0.17% | 0.07% |
Debt to Equity (MRQ) | 34.38 | 36.15 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $10.01 | $17.45 |
Cash per Share (MRQ) | $2.75 | $2.91 |
Operating Cash Flow (TTM) | $482.98M | $1.28B |
Levered Free Cash Flow (TTM) | $252.59M | $821.75M |
Dividends | ||
Last 12-Month Dividend Yield | 1.90% | 1.52% |
Last 12-Month Dividend | $0.50 | $0.21 |
Valuation & Enterprise Metrics Analysis: ChampionX vs Nov
Metric | CHX | NOV |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 17.09 | 11.32 |
Forward P/E | 13.04 | 8.78 |
PEG Ratio | 13.04 | -0.23 |
Price to Sales (TTM) | 1.38 | 0.58 |
Price to Book (MRQ) | 2.58 | 0.79 |
Market Capitalization | ||
Market Capitalization | $4.94B | $5.18B |
Enterprise Value | $4.87B | $6.43B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.36 | 0.73 |
Enterprise to EBITDA | 6.40 | 5.43 |
Risk & Other Metrics | ||
Beta | 1.51 | 1.26 |
Book Value per Share (MRQ) | $10.01 | $17.45 |
Financial Statements Comparison: ChampionX vs Nov
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | CHX | NOV |
---|---|---|
Revenue/Sales | $864.46M | $2.10B |
Cost of Goods Sold | $572.94M | $1.66B |
Gross Profit | $291.53M | $447.00M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $114.48M | $152.00M |
EBITDA | $179.17M | $232.00M |
Pre-Tax Income | $104.41M | $121.00M |
Income Tax | $15.38M | $47.00M |
Net Income (Profit) | $89.03M | $74.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | CHX | NOV |
---|---|---|
Cash & Equivalents | $526.56M | $1.16B |
Total Current Assets | $1.77B | $5.78B |
Total Current Liabilities | $784.90M | $2.18B |
Long-Term Debt | $633.17M | $2.23B |
Total Shareholders Equity | $1.90B | $6.49B |
Retained Earnings | $-171.24M | $-583.00M |
Property, Plant & Equipment | $1.54B | $2.49B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | CHX | NOV |
---|---|---|
Operating Cash Flow | $63.44M | $280.00M |
Capital Expenditures | $3.00M | $-84.00M |
Free Cash Flow | $35.55M | $51.00M |
Debt Repayment | $-5.38M | $-4.00M |
Common Stock Repurchase | $0 | $-81.00M |
Short Interest & Institutional Ownership Analysis
Metric | CHX | NOV |
---|---|---|
Shares Short | 4.50M | 29.03M |
Short Ratio | 1.56 | 9.22 |
Short % of Float | 0.03% | 0.17% |
Average Daily Volume (10 Day) | 2,539,777 | 3,723,450 |
Average Daily Volume (90 Day) | 2,969,606 | 3,578,040 |
Shares Outstanding | 190.70M | 381.55M |
Float Shares | 189.36M | 368.07M |
% Held by Insiders | 0.01% | 0.01% |
% Held by Institutions | 0.96% | 1.05% |
Dividend Analysis & Yield Comparison: ChampionX vs Nov
Metric | CHX | NOV |
---|---|---|
Last 12-Month Dividend | $0.50 | $0.21 |
Last 12-Month Dividend Yield | 1.90% | 1.52% |
3-Year Avg Annual Dividend | $0.39 | $0.21 |
3-Year Avg Dividend Yield | 0.31% | 0.35% |
3-Year Total Dividends | $1.17 | $0.63 |
Ex-Dividend Date | Jul 03, 2025 | Mar 14, 2025 |